Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio

<p>Combined Company to Trade on Nasdaq Under Ticker “TRML”Talaris Announces 1-for-10 Reverse Stock Split of Common Stock BOSTON, Oct. 17, 2023 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris”) today announced the results of the special meeting of its stockholders held on October 17, 2023. At the special meeting, Talaris’ stockholders voted in favor […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/talaris-therapeutics-announces-stockholder-approval-of-merger-with-tourmaline-bio/">Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>